Panelists discuss how leveraging resources such as patient assistance programs, insurance navigators, clinical trial databases, advocacy groups, and oncology support services can help overcome access ...

Key Takeaways Expert panel developed guidelines for onabotulinumtoxinA use in OAB, emphasizing patient experience and compliance. Recommendations cover patient counseling, pre-procedure urinalysis, ...

Jack Andrews, MD; Eugene Cone, MD; and Akshay Sood, MD, discuss how real-world safety and efficacy data for androgen receptor inhibitors (apalutamide, darolutamide, and enzalutamide) in nonmetastatic ...

Former President Joseph R. Biden’s recent diagnosis of metastatic prostate cancer has put prostate health back into the national spotlight. His courage in sharing his diagnosis, particularly at age 82 ...

The ZIRCON Trial and Molecular Imaging Main Discussion Topics: The ZIRCON trial evaluated a novel PET tracer (89Zr-TLX250) for characterizing small renal masses. The trial demonstrated high ...

Paul E. Dato, MD, discusses how bone-targeted therapies play an important supportive role in advanced prostate cancer, with recommendations for calcium and vitamin D supplementation, vitamin K2 ...

In this episode of Pearls & Perspectives, host Amy Pearlman, MD, sits down with Diane K. Newman, DNP, a nationally recognized expert in pelvic health, to explore the often-overlooked yet vitally ...

A large, retrospective study of nearly 200,000 patients with prostate cancer from the Epic Cosmos database revealed a rise in the use of GLP-1 and GIP/GLP-1 receptor agonists over the past decade, ...

There has been an explosion of treatment options in non–muscle invasive bladder cancer (NMIBC) in recent years, with even more coming down the pike. Many of these agents have demonstrated encouraging ...

The concept of BCG-unresponsive non–muscle-invasive bladder cancer has evolved significantly since its introduction in 2015. This designation is crucial for identifying patients who have received an ...

Molecular Imaging in Risk Stratification and Adjuvant Therapy Main Discussion Topics: Potential role in identifying patients appropriate for adjuvant pembrolizumab after nephrectomy Possible utility ...

In the phase 2 COMRADE trial (NCT03317392), reduced-dose olaparib (Lynparza) combined with radium-223 (Ra-223, Xofigo) significantly improved radiographic progression-free survival (rPFS) over Ra-223 ...